For the year ending 2025-12-31, XFOR made $35,113K in revenue. -$79,199K in net income. Net profit margin of -225.55%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 35,113 | 2,557 | ||
| Cost of revenue | 5,757 | 797 | ||
| Research and development | 72,723 | 81,643 | ||
| General and administrative | 43,516 | 61,518 | ||
| Gain on sale of non-financial asset | 0 | 105,000 | ||
| Total operating expenses | - | 38,958 | ||
| Total operating expense | -121,996 | - | ||
| Loss from operations | -86,883 | -36,401 | ||
| Interest income | 4,576 | 5,769 | ||
| Interest expense | 8,876 | 8,768 | ||
| Change in fair value of warrant liability | 12,778 | 1,928 | ||
| Other (expense) income, net | -753 | 332 | ||
| Total other income (expense), net | 7,725 | -739 | ||
| Loss before provision for income taxes | -79,158 | -37,140 | ||
| Provision for income taxes | 41 | 310 | ||
| Net loss | -79,199 | -37,450 | ||
| Net loss attributable to common stockholders | - | -37,450 | ||
| Basic EPS | -1.87 | -0.19 | ||
| Diluted EPS | -1.87 | -0.19 | ||
| Basic Average Shares | 42,292,818 | 201,062,211 | ||
| Diluted Average Shares | 42,292,818 | 201,062,211 | ||
X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals, Inc (XFOR)